Valuation: MRI Interventions Inc

Market Cap 539M 475M 438M 410M 767M 50.83B 782M 5.26B 2.04B 25.07B 2.02B 1.98B 87.23B P/E 2026 *
-16.1x
P/E 2027 * -19.1x
Enterprise Value 539M 475M 438M 410M 767M 50.83B 782M 5.26B 2.04B 25.07B 2.02B 1.98B 87.23B EV / Sales 2026 *
10.1x
EV / Sales 2027 * 8.41x
Free-Float
91.55%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 2017-11-06
Director of Finance/CFO 41 2020-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2014-03-09
Chairman 80 2021-02-03
Director/Board Member 49 2017-11-06
Change 5-day change 1-year change 3-year change Capi.($)
+24.88%-8.05% - - 556M
+4.87%+6.61%+21.72%-6.11% 174B
-0.33%-0.09%-23.18%+22.79% 143B
+5.53%+6.25%-4.36%-20.70% 127B
-2.50%-1.09%-57.30%-17.62% 67.78B
+3.12%+3.44%+18.21%-0.75% 50.07B
-0.84%-1.21%-27.01%-33.20% 43.84B
+3.92%+5.87%+11.89%+10.22% 35.78B
+3.35%+3.41%+6.45%+42.08% 35.07B
+1.82%+6.10%-9.86%-18.72% 28.99B
Average +4.38%+0.58%-7.05%-2.45% 78.38B
Weighted average by Cap. +2.52%+0.76%-5.48%-2.58%

Financials

2026 *2027 *
Net sales 53.13M 46.78M 43.15M 40.35M 75.61M 5.01B 77.02M 519M 201M 2.47B 199M 195M 8.6B 64.1M 56.43M 52.05M 48.68M 91.22M 6.04B 92.92M 626M 242M 2.98B 241M 235M 10.37B
Net income -33.07M -29.11M -26.85M -25.11M -47.06M -3.12B -47.93M -323M -125M -1.54B -124M -121M -5.35B -28.63M -25.21M -23.25M -21.75M -40.75M -2.7B -41.51M -279M -108M -1.33B -108M -105M -4.63B
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-